2025 HCPCS Code Q0239
Injection, bamlanivimab-xxxx, 700 mg
| Notice | HCPCS Q0239 terminated on April 16, 2021. |
| Short Description | Bamlanivimab-xxxx |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | April 17, 2021 |
| HCPCS Code Added Date | November 09, 2020 |
| HCPCS Pricing Indicator Code | 54 - Vaccinations |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | V - Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95 |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q4394 - Surgraft aca per sq cm
- Q4395 - Acelagraft per sq cm
- Q4396 - Natalin per sq cm
- Q4397 - Summit aaa per sq cm
- Q5001 - Hospice or home hlth in home
- Q5002 - Hospice/home hlth in asst lv
- Q5003 - Hospice in lt/non-skilled nf
- Q5004 - Hospice in snf
- Q5005 - Hospice, inpatient hospital
- Q5006 - Hospice in hospice facility
- Q5007 - Hospice in ltch
- Q5008 - Hospice in inpatient psych
- Q5009 - Hospice/home hlth, place nos
- Q5010 - Hospice home care in hospice
- Q5098 - Inj ustekinumab-srlf, 1 mg
- Q5099 - Inj ustekinumab-stba, 1 mg
- Q5100 - Inj ustekinumab-kfce, 1 mg
- Q5101 - Injection, zarxio
- Q5102 - Inj., infliximab biosimilar
- Q5103 - Injection, inflectra
